Where we're up to

graphic timeline of the ADAC project with all modules now in the last stage: 'Publish and disseminate'

Click image to enlarge

ADAC V4 Paediatric V4 is coming in October 2023!


eviQ Education are delivering face to face and online ‘train the trainer’ style sessions for Paedraitric facilitators to support implementation in their workplace.

Registrations for face to face training in Sydney on 26 October 2023 have closed.

Stay tuned to this page for online training dates.


What to expect with the new version of ADAC:

  1. New topic list including Treatment related toxicities and management
  2. Two exit points (Safe handling of hazardous drugs and related waste and Administering anti-cancer drugs) with related assessment strategies including eQuiz, Supervised clinical practice, Clinical skill workshop and Competency assessment.
  3. New workbook with key summary notes and activities
  4. Enhanced design elements, including animations, case studies, real clinical images and videos
  5. New competency system assessing the learner from dependent through to independent with level 6 representing advanced practice – an option for facilities who wish to recognise staff capable of performing the facilitator or assessor role.

Key module changes:

Module 1: Safe handling of hazardous drugs and related waste

There have been some exciting additions to Module 1, including:

  1. Brand new topic defining categories of hazardous drugs using NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings
  2. New section on control measures, using the hierarchy of control, including PPE.
  3. New risk management process of hazardous drugs including learning activity and workplace focus to contextualise local practice.
  4. New video! Hazardous drug spill management

Module 2: Understanding how anti-cancer drugs work 

Module 2 is dedicated to different drug classes, classifications and mechanisms of action. It includes targeted therapies, monoclonal antibodies, and immune checkpoint inhibitors, not just cytotoxic drugs.  

  1. Brand new content:
    1. Targeted therapies, including small molecule drugs and monoclonal antibodies
    2. Principles of anti-cancer drugs treatment, including drug classes, combination treatment and scheduling
    3. Immunotherapies, including immune checkpoint inhibitors 
    4. Drug interactions.
  2. New animations to explain the mechanisms of action of different agents  
  3. Case study exploring different classes of drugs in a treatment protocol.

Module 3: Treatment related toxicities and management 

Module 3 is totally new and focusses on treatment related toxicities and their management. 

  • A comprehensive toxicities list is categorised according to body system and aligned to the relevant eviQ clinical resources 
  • Each toxicity includes an overview of basic pathophysiology, management and key points for patient education  
  • Each body system is separated into a content block for easy access and re-fresher training 
  • Adverse events section including hypersensitivity reaction and oncological emergencies 

Module 4: Reviewing anti-cancer protocols and prescriptions 

  • New content! 
    • Principles of medication safety and practice
    • Clinical trials in the treatment of cancer including principles, phases and ethical consideration 
  • Nursing verification process using treatment protocol and medication chart 
  • Drug dose calculation including BSA, weight and age based dosing, dose escalation and dose modification   
  • Case study with nursing verification and dose calculation  

Module 5: Patient education   

New learning activity!

- Interactive case study featuring patient/nurse drag and drop activity to prepare the learner to deliver patient education. 

Module 6: Patient assessment

Brand new;

  • case study activity with role play and toxicities assessment 
  • overview of patient-reported outcome measures (PROMs)
  • Toxicity management including escalation, dose modification and cumulative toxicities 

Module 7: Administering anti-cancer drugs

Modules 6 and 7 from version 3 have been combined to make one module - module 7.

This module now includes all routes (not just orals) and has more flexibility – learners are only required to complete the eLearning and assessment on the route/s they administer. Learners can add other routes at a later stage.    

Thank you to our reviewers

We would like to thank our clinical advisory committee and external review group for generously giving their time and expertise to improve this course.

Clinical advisory committee

Beverly Hernandez Helen Starosta Liz Darch
Bridget Smith Jane Templeton Nicole Lennox
Chris Williams Jessica Nicholson Sally Wainhouse
Danielle Antionette Milner (Dani) Lisa Barrow Sara Hulbert
Hayley Vasileff Emma Zietsch  Natarsha Single 
Mandy Bartram Kendall Fairless  


Meet our subject matter expert: Rachel Edwards


Rachel Edwards


Rachel Edwards is an experienced Paediatric Oncology Nurse Educator, currently working in nursing research at Queensland Children’s Hospital. She has over 25 years’ experience caring for people with cancer.



Important documents

Learn more about eviQ Education